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Introduction
Cellular c-Src (Src) is a nonreceptor protein tyrosine kinase 
  associated with the plasma membrane, cell–matrix and cell–cell 
adhesions, and endosomal vesicles. It mediates signaling by a vari-
ety of receptors (Schlaepfer et al., 1999; Abram and Courtneidge, 
2000). Constitutively active Src can elicit cell transformation 
in vitro (Martin, 2001; Courtneidge, 2002; Frame, 2004), and Src 
expression and activity are elevated in many human epithelial 
cancers (Bjorge et al., 2000). The fi  rst 16 N-terminal residues 
of Src (residue numbers refer to chicken c-Src) contain an 
N-myristoylation site and a series of basic residues, both re-
quired for membrane association (Resh, 1999). Residues 17–84 
constitute a unique domain, followed by SH3 and SH2 domains 
connected by a short linker. Another linker connects the SH2 
domain to the kinase domain, which is required for most 
biological functions of Src. Tyr527 (or Tyr530 in human Src) 
undergoes an inhibitory phosphorylation by C-terminal Src 
kinase. In the inactive or “closed” form of Src, the SH2 domain 
interacts with pTyr527, positioning the SH3 domain to interact 
with a polyproline type II helix in the kinase-SH2 linker region. 
This causes inactivating conformational changes in the N-lobe 
of the kinase. Activation can occur as a result of dephosphory-
lation or mutation of Tyr527 or by binding of the SH2 or SH3 
domains to activating ligands (Martin, 2001; Courtneidge, 2002; 
Frame, 2004; Chong et al., 2005).
Src initiates intracellular signaling by binding to protein 
substrates via its SH3 and SH2 domains, often inducing their 
processive phosphorylation. For example, Src SH3-dependent 
binding to p130Cas initiates a tyrosine phosphorylation  cascade, 
in which the initially formed phosphotyrosyl (pTyr) residue 
binds to the Src SH2 domain, followed by phosphorylation at 
additional sites (Mayer et al., 1995). Thus, Src SH3 and SH2 
domains have dual roles, mediating inactivating intramolecular 
interactions as well as promoting substrate phosphorylation.
Membrane association is critical for Src signaling, as indi-
cated by the fi  nding that a mutation eliminating myristoylation 
blocks cell transformation by activated Src (Kamps et al., 1985; 
Buss et al., 1986). Other Src-family kinases (SFKs), such as 
Fyn, Yes, and Lck, are thought to reside in cholesterol-enriched 
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assemblies (commonly referred to as lipid rafts) and caveolae 
by virtue of their dual acylation (Shenoy-Scaria et al., 1994; 
Robbins et al., 1995; Resh, 1999; Janes et al., 2000). However, the 
single myristoyl in Src is not considered a strong raft-targeting 
signal (Melkonian et al., 1999), and reports on the raft association 
of Src were ambiguous (Shenoy-Scaria et al., 1994; Tansey et al., 
2000; Lee et al., 2002; Mukherjee et al., 2003; Chen et al., 2006; 
Veracini et al., 2006).
Despite the functional importance of Src membrane asso-
ciation, little is known about the dynamics of these interactions, 
and how different elements (the kinase, SH2, and SH3 domains) 
control Src membrane targeting and association with substrate 
proteins. We tackled these questions by studying a series of 
chicken c-Src mutants fused to GFP, combining FRAP beam-
size analysis (Henis et al., 2006) to determine their membrane 
association with biochemical studies to characterize their inter-
actions with pTyr protein targets. Our data demonstrate that 
wild-type (WT) Src displays lipid-like membrane association, 
whereas the open-conformation constitutively active Src-Y527F 
shows a substantial contribution of interactions with slower-
diffusing membrane-associated proteins. These interactions 
depend mutually on Src kinase activity and SH2 domain binding. 
The results suggest distinct and novel roles for Src kinase 
activity and SH2 and SH3 domains in regulating Src mem-
brane interactions.
Results
Interactions with membrane proteins 
contribute to the membrane association 
of activated but not nonactivated Src
To study the roles of Src kinase activity and SH3 and SH2 
domains in its interactions with the plasma membrane, we com-
bined biochemical studies with FRAP beam-size analysis in 
live cells (Illenberger et al., 2003; Henis et al., 2006). The latter 
approach characterizes the membrane interactions of inner-leafl  et 
proteins based on their lateral diffusion rates and on the relative 
contribution of exchange between membrane and cytosolic pools 
to their FRAP. These studies used a series of mutants of chicken 
c-Src with GFP fused at the C terminus (Table I).
To investigate whether Src activation affects its distri-
bution between cytosolic and membrane fractions, we trans-
fected COS-7 cells with Src-WT-GFP or constitutively active 
Src-Y527F-GFP and compared their membrane association by cell 
fractionation (Fig. 1) and FRAP (Figs. 2 and 3). Src-WT-GFP 
and Src-Y527F-GFP displayed a twofold higher percentage in 
the particulate (membrane) fraction (Fig. 1 A). The percentage 
of Src-Y527F-GFP in the membrane was slightly higher, possibly 
refl  ecting interactions with membrane-associated protein struc-
tures (e.g., focal adhesions) and peripheral membranes (Kaplan 
et al., 1994; Sandilands et al., 2004); this is in accord with the 
appearance of Src-Y527F-GFP in more distinct clusters, which 
partially colocalize with vinculin (Fig. 1 B).
To characterize the interactions of Src-GFP proteins with 
the plasma membrane, we conducted FRAP studies on live 
cells expressing Src-WT-GFP and Src-Y527F-GFP. Typical ex-
periments are shown in Fig. 2; quantitative results on multiple 
cells using two different laser beam sizes (beam-size analysis) 
are depicted in Fig. 3. The beam-size analysis (Henis et al., 
2006) explores membrane interactions of proteins interacting 
with the inner membrane leafl  et, where FRAP can occur not 
only by lateral diffusion but also by exchange between mem-
brane and cytoplasmic pools. If FRAP occurs solely by lateral 
diffusion, the characteristic fl  uorescence recovery time τ (t1/2 
for recovery) is the characteristic diffusion time, τD, propor-
tional to the area illuminated by the beam (τ = τD = ω
2/4D, 
where ω is the Gaussian radius of the beam and D is the lateral 
diffusion coeffi  cient; Petersen et al., 1986). When FRAP occurs 
by exchange, τ is the chemical relaxation time, which is inde-
pendent of the beam size (Henis et al., 2006). The τ(40×)/
τ(63×) ratio expected for the two beam sizes generated using 
the 40× and 63× objectives is 2.56 (the measured ratio between 
the illuminated areas) for recovery by pure lateral diffusion, 
versus 1 for exchange; inter  mediate values suggest a mixed re-
covery mode, where the faster process has a higher contribution 
(Henis et al., 2006).
In the current studies, we focused the laser beam on 
the nonadherent plasma membrane away from potential cell-
substrate contacts, although for the coverslip-attached COS cells 
(few focal adhesions), similar results were obtained on the 
adherent membranes. FRAP of a free cytoplasmic protein (GFP) 
was faster than the experimental time scale, ensuring that fast 
cytoplasmic diffusion does not contribute to the measurement 
(Fig. 2 A). In accord with the fractionation experiments, which 
demonstrated both membrane and cytoplasmic pools, the beam-
size analysis yielded τ(40×)/τ(63×) = 1.8 for Src-WT-GFP 
(FRAP by mixed lateral diffusion and exchange; Fig. 3). The 
contribution of exchange precludes an accurate translation of 
τ to D, but D can be estimated from τ(63×), because the smaller 
beam area reduces the characteristic diffusion time τD; as τ for 
Table I. Src-GFP mutants
Src mutant Description
Src-WT-GFP WT chicken c-Src
Src-K295M-GFP Kinase-dead mutant
Src-Y527F-GFP Y527F mutation, open conformation, 
 constitutively active
Src-Y527F/K295M-GFP Double mutant, open conformation, 
 kinase dead
Src-Y527F/R175A-GFP Double mutant, open conformation, 
 inactivated SH2 domain
Src-Y527F/W118A-GFP Double mutant, open conformation,
 inactivated  SH3 domain
Src-Y527F/K295M/
 R175A-GFP
Triple mutant, open conformation, 
 kinase dead, inactivated SH2
Src-251-GFP Truncated N-terminal half, containing 
 SH3/SH2 domains, no kinase region
Table shows Src-GFP constructs used in the studies. Chicken c-Src-WT-GFP was 
shown to undergo normal regulation in cells; Src-Y527F-GFP and Src-251-GFP 
were demonstrated to be active and possess correct cellular localization (Timpson 
et al., 2001; Sandilands et al., 2004). Additional mutants were constructed 
by site-directed mutagenesis using Src-WT-GFP or Src-Y527F-GFP as templates; 
the Y527F/K295M double mutant served as a template for the triple mutant. 
All constructs are in pEGFP-N1, except Src-251-GFP (pBabePuro). The K295M 
mutation inactivates Src kinase activity (Kamps et al., 1984; Kamps and Sefton, 
1986), the R175A mutation inactivates pTyr binding by the SH2 domain 
(Waksman et al., 1993), and the W118A mutation inactivates SH3 domain 
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exchange does not depend on the beam size, this results in a 
higher contribution of lateral diffusion to the recovery with the 
smaller beam size (Henis et al., 2006). This yields D = 0.57 μm
2/s 
(Fig. 2 B and Fig. 3 A) for Src-WT, close to D determined by 
fl  uorescence correlation spectroscopy (Larson et al., 2005) for 
the dually acylated SFK Lyn-GFP (0.3 μm
2/s) and to the D 
value we have measured for a lipid probe (DiIC16; 1 μm
2/s) in 
COS-7 cells (Rotblat et al., 2004). The membrane association of 
Src-WT-GFP is therefore mediated mainly by lipid-like inter-
actions, presumably via its myristoyl residue and N-terminal re-
gion. On the other hand, constitutively active Src-Y527F-GFP 
exhibited markedly slower FRAP rates and a minor increase in 
the τ(40×)/τ(63×) ratio to 2.2 (Fig. 2 C and Fig. 3). An elevated 
τ ratio suggests that the exchange rate is slowed relative to 
the lateral diffusion, in line with the slightly higher membrane 
fraction of Src-Y527F-GFP (Fig. 1 A). Yet, both τ(63×) and 
τ(40×) of Src-Y527F were strongly elevated, indicating that both 
exchange and lateral diffusion are inhibited, with a somewhat 
stronger effect on the exchange rate. Calculating D of Src-
Y527F-GFP from τ(63×) yields D = 0.20 μm
2/s (Fig. 2 C and 
Fig. 3 A), approximately fi  vefold slower than the lipid probe. 
This suggests that interactions with transmembrane (TM) and/
or membrane-associated proteins (whose lateral diffusion is 
slower than lipids) considerably contribute to the membrane 
association of Src-Y527F. The observed differences between 
Src-Y527F and Src-WT are not due to effects of Src activity on 
the membrane, as overexpression of constitutively active human 
c-Src-Y530F (10-fold excess plasmid DNA over Src-WT-GFP) 
did not affect the FRAP parameters of Src-WT-GFP (unpub-
lished data).
Figure 1.  Membrane association and cellular distribution of Src-WT-GFP and Src-Y527F-GFP. COS-7 cells were transfected with one of the above con-
structs as described under Materials and methods. (A) Percentage of Src-GFP in supernatant (S; cytosol) and pellet (P; membrane). After subcellular fraction-
ation, equal proportions (5% vol/vol) of each fraction were quantiﬁ  ed by immunoblotting. The immunoblot (IB) panels (blotting for GFP to identify Src-GFP 
proteins or for lactate dehydrogenase [LDH] and caveolin1 [Cav1] as cytosolic and membrane markers, respectively) are from a representative experiment, 
whereas the bar graph shows means ± SEM (n = 3) of multiple experiments. The percentage of Src-Y527F-GFP in pellet was somewhat higher, but the 
difference was not signiﬁ  cant (P > 0.05; t test). (B) Cellular distribution of Src-WT-GFP and Src-Y527F-GFP. Transfected cells were ﬁ  xed, permeabilized, 
and immunostained for vinculin (1:100 dilution of mouse anti-vinculin ascites, followed by 30 μg/ml Cy3 goat anti–mouse IgG). Fluorescence confocal 
imaging was as described in Materials and methods. Arrowheads point at vinculin (red) in focal adhesions; arrows indicate colocalization of Src (observed 
for Src-Y527F-GFP but not for Src-WT-GFP) with vinculin. Bar, 10 μm.
Figure 2.  Typical curves showing that the FRAP 
rate of Src-Y527F-GFP is slow relative to that of 
Src-WT-GFP. FRAP experiments were conducted 
at 22°C on COS-7 cells transiently expressing 
EGFP (GFP; A), Src-WT-GFP (B), or Src-Y527F-
GFP (C), using the 63× objective (see Materials 
and methods). Solid lines show the best ﬁ  t of a 
nonlinear regression analysis, with the resulting 
τ and mobile fraction (Rf) values. (A) Free GFP 
recovers instantaneously on the experimental 
time scale, demonstrating that free diffusion in the 
cytoplasm does not contribute to the measure-
ments in the other panels. (B and C) Src-WT-GFP 
displays slower FRAP enabling measurement 
of τ, whereas Src-Y527F-GFP exhibits a further 
notable reduction in the recovery kinetics.JCB • VOLUME 178 • NUMBER 4 • 2007  678
The aforementioned experiments were conducted on cells 
grown with 10% FCS, conditions that may activate part of 
the Src-WT population. However, the percentage of activated 
Src-WT molecules is low, as indicated by the small (although 
signifi  cant; P < 0.02, t test) effect of serum starvation on τ(63×) 
and τ(40×) of Src-WT-GFP (Fig. 3). The slight increase in the 
FRAP rate of Src-WT under these conditions (to D = 0.72 μm
2/s, 
as calculated from τ[63×]), together with the lack of effect on 
the τ values of constitutively active Src-Y527F-GFP (unpub-
lished data), suggests that only a minor fraction of Src-WT is 
activated in cells grown continuously in the presence of serum. 
Accordingly, all the FRAP parameters of Src-WT in the presence 
of serum were similar to those of the kinase-dead Src-K295M 
mutant (P > 0.2). Therefore, as serum starvation may induce 
apoptosis, further comparisons between Src-GFP mutants were 
conducted on unstarved cells.
Importantly, activation of Src-WT-GFP in serum-starved 
cells by PDGF signifi  cantly increased the τ values of Src-WT-
GFP, suggesting a retardation in the FRAP kinetics (Fig. 3 C). 
This effect is in the same direction as that induced by the consti-
tutively activating mutation (Y527F) but is considerably milder; 
this is not surprising considering the modest activation of Src-
WT in PDGF-treated cells (Abram and Courtneidge, 2000; 
Sandilands et al., 2004).
The mobility-restricting interactions 
of Src-Y527F-GFP with the plasma 
membrane depend mainly on its kinase 
activity and SH2 domain
To explore the roles of Src kinase activity and SH2 and SH3 
domains in the membrane association of Src-Y527F, we used 
FRAP beam-size analysis to investigate a series of Src-GFP mu-
tants (Fig. 4). Inactivating Src kinase by a second mutation in 
Src-Y527F (Src-Y527F/K295M) strongly reduced τ(63×) and 
τ(40×), bringing them close to those of Src-WT (Fig. 4 A). 
Analogous effects followed SH2 inactivation (Src-Y527F/R175A) 
or deletion of the kinase domain (Src-251). Calculation of D 
from τ(63×) shows that these mutants revert to lipid-like diffu-
sion (D  0.5 μm
2/s). The triple mutant Src-Y527F/K295M/
R175A, which lacks both kinase activity and SH2 binding, ex-
hibited somewhat faster FRAP rates than Src-Y527F/K295M or 
Src-251 (D = 0.72 μm
2/s); the latter two possess an exposed SH2 
domain that can bind pTyr residues generated by endogenous 
SFKs. In contrast, SH3 domain inactivation (Src-Y527F/W118A) 
did not enhance the FRAP rates and mildly increased τ(63×) 
and τ(40×) (Fig. 4 A). The further retardation (D = 0.13 μm
2/s; 
calculated from τ[63×]) suggests enhanced interactions with 
slower-diffusing membrane proteins. Collectively, these fi  nd-
ings suggest that the mobility-restricting membrane inter-
actions of Src-Y527F depend on its kinase activity and SH2 
Figure 3.  FRAP beam-size analysis of the membrane interactions of Src-
WT-GFP and Src-Y527F-GFP. FRAP experiments were conducted as in Fig. 2 
on cells grown with 10% FCS (A and B) or on serum-starved cells with or 
without PDGF stimulation (C and D). Bars are means ± SEM of 40–60 
measurements. Two beam sizes were generated using 63× and 40× ob-
jectives, and the τ values were determined with each. The ratio between 
the areas illuminated by the two beams was 2.56 ± 0.30 (n = 39); this 
ratio (B and D, solid lines) is expected for FRAP by lateral diffusion, 
whereas a ratio of 1 (broken lines) is expected for recovery by exchange 
(Henis et al., 2006). The Rf values were high in all cases (averaging 0.98 
for Src-WT-GFP and 0.92 for Src-Y527F-GFP). (A) τ values in unstarved 
cells. The differences between the τ(63×) or τ(40×) values of Src-Y527F 
and Src-WT were highly signiﬁ  cant, comparing the two proteins with the 
same beam size (***, P < 10
−17; t test). (B) τ(40×)/τ(63×) ratios in un-
starved cells. The τ ratio of Src-WT-GFP (but not of Src-Y527F-GFP) differed 
signiﬁ  cantly from the 2.56 ratio between the measured beam sizes (P < 
0.005). (C) Effects of serum starvation and PDGF on the τ values of Src-
WT-GFP. PDGF stimulation (see Materials and methods) signiﬁ  cantly  in-
creased the τ values of Src-WT (**, P < 10
−9). (D) τ(40×)/τ(63×) ratios 
derived from C. Both τ ratios are signiﬁ  cantly below the 2.56 beam-size 
ratio (P < 0.05).
Figure 4.  FRAP studies demonstrate distinct roles for Src kinase activity 
and SH2 and SH3 domains in Src membrane interactions. FRAP experi-
ments were conducted as in Fig. 3. Results are mean ± SEM of 40–60 
measurements. The Rf values were high in all cases (≥0.92; not depicted). 
(A)  τ values. Asterisks indicate signiﬁ   cant differences from τ(63×) or 
τ(40×) measured for Src-Y527F-GFP (**, P < 0.001; ***, P < 10
−7). 
(B) τ(40×)/τ(63×) ratios. Only the τ(40×)/τ(63×) ratio of Src-Y527F/
W118A is signiﬁ  cantly different from 2.56 ± 0.3 (*, P < 0.005). The 
D values calculated for the various mutants are given in the text.DYNAMICS OF SRC MEMBRANE INTERACTIONS • SHVARTSMAN ET AL. 679
binding, whereas SH3 binding is dispensable. This does not imply 
that the SH3 domain cannot bind Src target proteins (Fig. 5 C); 
however, the generally lower binding affi  nities of Src SH3 rela-
tive to SH2 (Li, 2005; Liu et al., 2006) may render SH3 binding 
ineffective in retarding the dif  fusion of Src-Y527F. Moreover, 
the conformational change mediated by the SH3-inactivating 
mutation enhances Src kinase activity (Kanner et al., 1991; 
Erpel et al., 1995; Chong et al., 2005), potentially compensating 
for the loss of SH3 binding by generating more pTyr residues 
that can enhance Src binding via the SH2 domain. This could 
lead to the additional increase in τ(63×) and τ(40×) observed 
for Src-Y527F/W118A (Fig. 4). The SH2 mutation (R175A), 
in contrast, does not affect the catalytic activity of Src-Y527F 
because the intramolecular interaction between the SH2 domain 
and the C-terminal region is already disrupted by the Y527F 
mutation (Superti-Furga and Gonfl  oni, 1997).
All Src-GFP mutants except Src-Y527F/W118A exhibited 
τ ratios not signifi  cantly different from the 2.56 ± 0.3 ratio 
expected for recovery by lateral diffusion, suggesting low con-
tribution of exchange. This contrasts with Src-WT, whose τ ratio 
was signifi  cantly below 2.56 (P < 0.005; Fig. 3 B). Thus, shift-
ing to an open conformation may have a minor effect on the in-
sertion of the N-terminal anchor of Src in the membrane. Unlike 
Src-Y527F, the τ ratio of Src-Y527F/W118A was signifi  cantly 
lower than 2.56 (P < 0.005; Fig. 4 B), suggesting a higher rela-
tive contribution of exchange. A simple explanation may be that 
SH3 domain binding (lost in this mutant) retards mainly the ex-
change kinetics. However, because the τ ratio is sensitive to the 
relative rate of exchange versus lateral diffusion, an alternative 
explanation is that the retardation of exchange by SH3 binding is 
negligible, and the higher contribution of exchange is due to the 
slower diffusion mediated by the SH3-inactivating mutation.
Figure 5.  Binding of pTyr proteins from cells expressing Src-GFP mutants to GST-Src domain fusion proteins. COS-7 cells were transfected with vectors en-
coding different Src-GFP proteins or GFP (control) and lysed (see Materials and methods). After protein and Src-GFP level determination, 6 aliquots (0.5 mg 
protein) from each lysate were precipitated by GST-Src domain fusion proteins coupled to glutathione–Sepharose beads, followed by 8.5% SDS-PAGE 
and immunoblotting. The GST-Src domain constructs (see Table S2, available at http://www.jcb.org/cgi/content/full/jcb.200701133/DC1) were as 
follows: GST-SH3, GST-SH2, GST-SH3/SH2 (including both domains), GST-SH3/SH2* (SH2 with R175A mutation), and GST-SH3*/SH2 (SH3 with 
W118A mutation). A and B depict a representative experiment, whereas C gives the means ± SEM (n = 3) of multiple experiments. (A) Typical blots of 
pTyr proteins precipitated from cells transfected with the indicated Src-GFP plasmids. Blots were probed with mouse anti-pTyr followed by IRDye 800 goat 
anti–mouse IgG. Although many pTyr proteins are precipitated by both GST-SH2 and GST-SH3, presumably because they contain binding sites for both, 
some are precipitated selectively by one but not the other (right, asterisks). (B) Expression levels of the Src-GFP proteins in the cells shown in A. From each 
lysate, 25 μg protein was resolved by 8.5% SDS-PAGE and immunoblotted with rabbit anti-GFP and Alexa 680 goat anti–rabbit IgG. (C) Quantiﬁ  cation 
of precipitated pTyr proteins. Results are mean ± SEM of three experiments. For each lane shown in A, the sum of the intensities of all bands (the cumulative 
pTyr precipitated by a speciﬁ  c GST fusion protein) was calibrated according to the Src-GFP level in the same transfection (B). The results are presented rela-
tive to the calibrated level of pTyr proteins precipitated by GST-SH3/SH2 from cells transfected with Src-Y527F-GFP within each set of experiments, taking 
this value as 100.JCB • VOLUME 178 • NUMBER 4 • 2007  680
Src SH2 and SH3 domains bind pTyr 
proteins, whose formation depends 
on Src kinase activity and SH2 domain
To study the interactions of Src with its target proteins, we con-
structed GST fusion proteins with specifi  c Src domains; the fu-
sion proteins were coupled to glutathione–Sepharose beads and 
used to precipitate Src binding proteins from cells expressing 
different Src-GFP mutants (Fig. 5). The precipitated proteins 
were quantifi  ed by Western blotting using anti-pTyr antibodies. 
The specifi  city of precipitation by such fusion proteins, estab-
lished in many previous studies, was confi  rmed by a compari-
son of the pTyr proteins in lysates and in precipitates, by the 
inability of GST alone to precipitate pTyr proteins, and by the 
ability of free pTyr to compete with precipitation by the GST-
SH2 fusion (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200701133/DC1). Comparison between lysates of cells 
transfected by different Src-GFP mutants measures the abun-
dance of pTyr proteins generated in vivo by each Src mutant. 
The precipitated pTyr proteins were generated mainly by the 
expressed Src-GFP proteins, as suggested by the low pTyr levels 
in cells transfected with GFP or with Src-WT-GFP (Fig. 5). 
The results demonstrate a requirement for Src kinase activity 
(compare cells expressing Src-Y527F with K295M mutants). 
The SH2-inactivating mutation (R175A) reduced the levels of 
precipitated pTyr proteins to about half of the level generated by 
Src-Y527F, consistent with previous fi  ndings on SH2-dependent 
multisite processive phosphorylation (Mayer et al., 1995; Pellicena 
and Miller, 2001), consistent with the FRAP results (Fig. 4) 
showing a mutual dependence on Src kinase activity and SH2 
domain. On the other hand, Src-Y527F/W118A (inactive SH3) 
generated amounts of pTyr proteins similar to those of Src-
Y527F (Fig. 5), in line with the reports that SH3 inactivation 
increases Src kinase activity (Seidel-Dugan et al., 1992; Erpel 
et al., 1995; Chong et al., 2005) and thus can compensate for 
loss of SH3 binding to substrates. The high pTyr levels gener-
ated by this mutant provide multiple pTyr sites that it can bind 
via its SH2 domain, providing increased interactions that can 
further retard the recovery (Fig. 4).
In the affi  nity precipitation studies, the lysate from cells 
transfected by a given Src-GFP mutant was divided into ali-
quots, each precipitated by beads coupled to a specifi  c GST-Src 
domain. The highest pTyr level was in cells transfected by Src-
Y527F; GST-SH2 and GST-SH3 precipitated similar amounts 
of pTyr proteins (Fig. 5 C, third histogram). GST-SH3/SH2 was 
twice as effective, whereas inactivating SH3 or SH2 compro-
mised the pull-down capacity. This distribution was retained 
in cells transfected by all the Src mutants, except Src-Y527F/
W118A. The pTyr proteins generated by the latter mutant are 
precipitated more effectively by GST-SH2 (Fig. 5 C, compare 
the blue bars). This may refl  ect preferential phosphorylation of 
target proteins to which the SH3-inactive Src mutant binds via 
its SH2 domain.
Overexpression of paxillin-DsRed2 
interferes with the mobility-restricting 
interactions of Src-Y527F-GFP
We next examined the ability of paxillin, a peripheral membrane-
associated Src substrate, to compete for binding to activated 
Src. We chose to overexpress paxillin, because although it is 
found in focal adhesions, it has a large cytoplasmic pool (see 
Fig. 7 B) and exhibits fast turnover between the pools (Webb 
et al., 2004; Digman et al., 2005). Cells were cotransfected with 
Src-GFP and an excess of paxillin-DsRed2 and subjected to 
FRAP beam-size analysis (Fig. 6). None of the FRAP parame-
ters of Src-WT were signifi  cantly altered, in line with the low 
level of pTyr proteins in cells expressing Src-WT-GFP. On the 
other hand, τ(63×), τ(40×), and the τ ratio of Src-Y527F were 
strongly reduced to values resembling those of Src-WT (Fig. 6). 
Thus, excess paxillin appears to compete with the mobility-
restricting binding of Src-Y527F to membrane protein targets, 
leaving Src-Y527F anchored in the membrane mainly by lipid-
like interactions. This interpretation is supported by the fi  nding 
that overexpression of paxillin-DsRed2 reduces the coimmuno-
precipitation of Src-Y527F with FAK, a known Src substrate 
(Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb
.200701133/DC1). Moreover, mutation of the tyrosine phosphoryl-
ation sites on paxillin (paxillin-Y31F/W118F; Zaidel-Bar et al., 
2007) signifi  cantly compromised the ability of the mutated 
paxillin-Y31F/Y118F-DsRed2 to affect the FRAP of Src-Y527F 
(Fig. 6). The incomplete loss of the effect is most likely due 
to the fact that paxillin contains not only SH2 but also SH3 
binding sites (Schaller, 2001; Cary et al., 2002), which can con-
tribute to Src binding via its SH3 domain. This notion is sup-
ported by the demonstration (Fig. 6) that inactivation of the SH3 
domain in Src-Y527F/W118A, which retains an active SH2 
Figure 6.  FRAP studies on the effects of paxillin-DsRed2 on Src membrane 
interactions.  COS-7 cells were transfected with Src-GFP and paxillin-
DsRed2 or paxillin-Y31F/Y118F-DsRed2 (Pax-2F; 1:10 DNA ratio) as indi-
cated in B. Coexpressing cells were selected by their ﬂ  uorescence  and 
subjected to FRAP studies on Src-GFP as in Fig. 4. Results are mean ± SEM 
of 40–60 measurements. The Rf values were high in all cases (≥0.92; not 
depicted). (A) τ values. Asterisks indicate signiﬁ  cant differences between 
the τ(63×) or τ(40×) values, comparing cells expressing Src-GFP alone 
versus cells coexpressing Src-GFP and paxillin-DsRed2 (*, P < 0.05; **, 
P < 0.001; ***, P < 10
−7). (B) τ(40×)/τ(63×) ratios. Statistical analysis 
comparing the effects of paxillin expression on the τ ratios of speciﬁ  c Src-
GFP proteins (Src-GFP alone vs. Src-GFP coexpressed with paxillin-DsRed2 
or Pax-2F) showed signiﬁ  cant effects only for Src-Y527F and Src-Y527F/
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domain, results in a small but distinct reduction in the ability 
of paxillin to affect the FRAP parameters of this Src mutant; 
this is shown by the lesser effect of overexpressed paxillin-
DsRed2 on the τ values of Src-Y527F/W118A as compared 
with Src-Y527F (Fig. 6 A) and the insignifi  cant effect on its 
τ(40×)/τ(63×) ratio (Fig. 6 B). The τ values of all the other 
Src-Y527F double mutants, which contain either kinase-dead 
or SH2-inactivating mutations, were only weakly affected by 
paxillin overexpression (Fig. 6), in line with their mainly lipid-
like interactions with the membrane even in the absence of 
paxillin overexpression. The high sensitivity of Src-Y527F and 
Src-Y527F/W118A, which are the most effective in generating 
pTyr proteins and possess SH2 binding, to competition by paxillin 
is consistent with the major role of Src kinase activity and SH2 
binding in the mobility-restricting interactions with membrane-
associated proteins.
In accord with the requirement for Src kinase activity, 
kinase-dead Src-Y527F/K295M, which exhibited lipid-like mem-
brane interactions to begin with, did not show a signifi  cant 
modulation in τ(63×), suggesting that D is not altered, upon 
expression of paxillin-DsRed2 (Fig. 6 A). However, its τ(40×) 
and τ(40×)/τ(63×) ratio were signifi  cantly reduced (Fig. 6), 
suggesting a higher contribution of exchange. This may refl  ect 
an ability of this mutant to bind paxillin via its SH3 domain, 
with a potential contribution of SH2 binding to pTyr-paxillin-
DsRed2 generated to some degree by endogenous SFKs. The 
FRAP rates of Src-Y527F/R175A (inactivated SH2 domain) were 
only weakly affected (Fig. 6 A), consistent with SH3 binding to 
target proteins being much less effective than SH2 binding both 
in mediating mobility-restricting interactions and in competing 
for them.
We next examined the effects of paxillin-DsRed2 on the 
membrane-cytosol distribution of Src-WT and Src-Y527F (Fig. 
7 A). Overexpression of paxillin-DsRed2 had no signifi  cant 
effects on the percentage of Src-WT-GFP in either fraction and 
induced a modest increase in the pellet fraction of Src-Y527F-
GFP. This indicates that paxillin competition shifts Src-Y527F 
to membrane interactions that are mainly lipid-like, resembling 
Src-WT (Fig. 6). Yet, these interactions are suffi  cient to retain a 
high percentage in the particulate fraction (as observed also for 
Src-WT). At the same time, the ability of overexpressed paxillin 
to reverse the retarding interactions of activated Src with mem-
brane proteins suggests that paxillin itself does not associate 
tightly with the membrane and is mainly cytoplasmic in these 
cells. We therefore combined subcellular fractionation with 
paxillin immunoprecipitation to investigate the distribution of 
Figure 7.  Paxillin and paxillin-DsRed2 display 
high cytoplasmic fractions and are tyrosine 
phosphorylated by coexpressed Src-Y527F-GFP. 
COS-7 cells were cotransfected with vectors 
encoding Src-WT-GFP or Src-Y527F-GFP and 
paxillin-DsRed2 (Pax-DsRed2) or empty vector 
(1:10 DNA ratio). (A) Distribution of Src-GFP 
between cytosolic (S) and pellet (P) fractions. 
Subcellular fractionation, immunoblotting, and 
quantiﬁ  cation were conducted as in Fig. 1 A. 
The blots depict representative experiments; 
bars are mean ± SEM (n = 3) of multiple 
  ex  periments. Over  expression of paxillin-DsRed2 
slightly increased the percentage in pellet of 
Src-Y527F (*, P < 0.05). (B) Distribution and 
tyrosine phosphorylation of endogenous paxil-
lin (Endo. Pax) and paxillin-DsRed2. Equal 
percentages (vol/vol) of each fraction were 
immunoprecipitated (IP) by anti-paxillin, followed 
by SDS-PAGE and immunoblotting (IB) with anti-
pTyr (top) or anti-paxillin (middle; representative 
experiments). Bars depict means ± SEM (n = 3) 
of multiple experiments. To quantify pTyr in the 
paxillin and paxillin-DsRed2 bands, the sum of 
their intensities in each lane of the pTyr blots 
was calibrated according to the total paxillin 
level (paxillin-DsRed2 plus endogenous paxil-
lin in both the cytosolic and pellet fractions) in 
the same transfection. The results are presented 
relative to the calibrated pTyr level precipitated 
from the cytosolic fraction of cells cotransfected 
with Src-Y527F and paxillin-DsRed2, taking 
this value as 100. Src-Y527F increased the 
levels of pTyr-paxillin and pTyr-paxillin-DsRed2 
in both cytosolic and pellet to a signiﬁ  cantly 
higher level than Src-WT (P < 0.001). (C) Cel-
lular distribution of paxillin-DsRed2 coexpressed 
with Src-WT-GFP or Src-Y527F-GFP. Confocal 
images were obtained as in Fig. 1 B. Arrows 
indicate Src-GFP and paxillin-DsRed2 colocal-
ized spots (observed for Src-Y527F-GFP but 
not for Src-WT-GFP). Bar, 20 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  682
paxillin-DsRed2, endogenous paxillin, and their pTyr levels in 
cells transfected with Src-WT-GFP or Src-Y527F-GFP alone or 
together with paxillin-DsRed2 (Fig. 7 B). A higher percentage 
of paxillin and paxillin-DsRed2 was in the cytosolic fraction in 
cells expressing Src-WT (84% of the total paxillin and paxillin-
DsRed2) and Src-Y527F (82%; Fig. 7 B, middle). pTyr-paxillin 
and pTyr-paxillin-DsRed2 had a similar distribution (76–81% 
cytosolic) in these cells. Importantly, expression of Src-Y527F-
GFP as compared with Src-WT-GFP signifi  cantly increased 
the levels of all pTyr-paxillin proteins (P < 0.001; Fig. 7 B). 
Thus, although a fraction of paxillin is membrane associated, 
a major fraction is cytoplasmic, and both are subject to tyro-
sine phosphorylation by the coexpressed Src-Y527F-GFP. This 
is in accord with the ability of paxillin-DsRed2 to compete with 
membrane-associated Src substrates for binding Src-Y527F, 
and with the partial colocalization observed by confocal micros-
copy between the subpopulation of paxillin-DsRed2 found in 
clusters and Src-Y527F-GFP but not Src-WT-GFP (Fig. 7 C).
Discussion
The studies reported here indicate that Src association with the 
plasma membrane is dynamic and that there are major differ-
ences between the membrane interactions of Src-WT (closed 
conformation) and Src-Y527F (activated open conformation). 
We demonstrate that these differences are mediated by transient 
binding of Src-Y527F to target proteins in the membrane, which 
depend on Src kinase activity and its SH2 domain, and propose 
a mechanism for the regulation of Src membrane association by 
its specifi  c domains.
A major fraction of Src-WT-GFP and Src-Y527F-GFP is 
membrane associated, but they both display signifi  cant cytosolic 
fractions (Fig. 1 A). This is in accord with a recent study on the 
SFK Lyn-GFP, which detected a fast-diffusing cytoplasmic pop-
ulation both before and after stimulation (Larson et al., 2005). 
Although the membrane fraction of Src-Y527F is only slightly 
higher then that of Src-WT (Fig. 1 A), their association with the 
membrane is very different, as indicated by the FRAP studies 
(Figs. 2 and 3). The lateral diffusion of Src-WT in the plasma 
membrane (D  0.6 μm
2/s) is close to the values measured for a 
lipid probe (see Results) and for the membrane-associated popu-
lation of Lyn-GFP (Larson et al., 2005), suggesting that, at steady 
state, the large majority of Src-WT has no considerable inter-
actions with slower-diffusing TM proteins. The Src N-terminal 
domain contains an N-myristoyl anchor and a polybasic cluster 
(Resh, 1999), resembling the C-terminal farnesylated lipid an-
chor domain of K-Ras (Hancock and Parton, 2005). In contrast, 
the lateral diffusion of Src-Y527F is threefold slower, implying 
that it is retarded by interactions with TM and/or membrane-
  associated proteins (Figs. 2 and 3). The biological relevance of 
this difference is supported by the observation that PDGF, an 
  established activator of Src (Broome and Hunter, 1996; Abram 
and Courtneidge, 2000), induces a signifi  cant retardation in the 
FRAP kinetics of Src-WT-GFP (Fig. 3 C). This effect is smaller 
than the mobility retardation of the constitutively active Src-
Y527F-GFP, presumably because only a fraction of the Src-WT-
GFP molecules are activated by PDGF. This is in line with the 
modest activation of Src-WT after PDGF stimulation (Abram 
and Courtneidge, 2000; Sandilands et al., 2004).
The threefold slower FRAP kinetics of Src-Y527F indi-
cate that its mobility-retarding interactions are transient (dy-
namic), as stable binding to target membrane proteins, which 
typically diffuse 10–100-fold slower than lipids (Edidin, 1992; 
Jacobson et al., 1995), would inhibit D to a much higher degree. 
In line with these fi  ndings, only a mild retardation of D was ob-
served also for Lyn after antigen stimulation of IgE receptors 
(Larson et al., 2005) and for Lck after cross-linking of T cell 
receptors (Kusumi et al., 2005). Moreover, because the mobility-
restricting interactions of Src are largely mediated by its SH2 
domain (Figs. 4 and 5; discussed in the following paragraph), 
their dynamic nature is in accord with the report that high-affi  nity 
binding of SH2 domains to pTyr peptides is accompanied by 
rapid dissociation and exchange kinetics (Felder et al., 1993; 
Ladbury et al., 1995). The interactions of Src-Y527F with mem-
brane proteins retard its exchange rate to an even higher degree 
than its lateral diffusion, as suggested by the mild increase 
(from 1.8 to 2.2) in the τ(40×)/τ(63×) ratio (Henis et al., 2006; 
see Results). This correlates with the minor increase in Src-Y527F 
membrane association relative to Src-WT (Fig. 1 A).
To identify the Src domains responsible for the mobility-
retarding interactions of constitutively active Src, we deter-
mined the effects of second mutations in Src-Y527F on the 
FRAP parameters (Fig. 4). The mobility retardation required 
both an intact SH2 domain and Src kinase activity, as shown by 
the shift to lipid-like diffusion (resembling Src-WT) after func-
tional inactivation of the SH2 domain, Src kinase inactivation, 
or deletion of the entire catalytic segment. The SH3 domain has 
only a minor contribution to the mobility-restricting interactions, 
as its inactivation (Src-Y527F/W118A) did not eliminate the 
mobility retardation, which was even modestly enhanced (Fig. 4). 
These observations suggest that the mobility-restricting inter-
actions of activated Src are mediated mainly by the binding of 
SH2 domain to pTyr residues in membrane-associated proteins. 
Formally, we cannot exclude the possibility that some of these 
pTyr residues are phosphorylated by Src-activated tyrosine kinases 
rather then directly by Src. However, studies with modifi  ed forms 
of Src that accept chemically modifi  ed nucleotides indicated that 
many pTyr proteins in Src-transfected cells are indeed the result of 
direct phosphorylation by Src (Shah et al., 1997). Thus, it appears 
that the modulation in Src-Y527F FRAP kinetics is mediated 
largely by its binding to membrane-associated protein substrates 
that it has itself directly phosphorylated (Fig. 8 A).
The effects of the aforementioned mutations on Src-Y527F 
FRAP parameters were paralleled by their effects on the abun-
dance of pTyr proteins that can be recognized in vitro by the 
Src noncatalytic domains (Fig. 5). In particular, inactivation of 
the catalytic domain reduced the abundance of these proteins 
below the level observed in cells overexpressing Src-WT, and 
inactivation of the SH2 domain strongly reduced their level. 
In vitro the Src SH3 domain can bind to Src substrates (Fig. 5). 
However, in agreement with the dispensability of the SH3 
domain for the mobility retardation of Src-Y527F, its inactiva-
tion in vivo hardly affected the abundance of the pTyr proteins 
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inhibition indicates that in vivo the interactions of SH3 with tar-
get proteins, which are weaker than those of SH2 domains (Li, 
2005; Liu et al., 2006), are too weak and labile to strongly retard 
the dynamic parameters. In fact, the SH3 mutation (Src-Y527F/
W118A) was not simply ineffective but induced a further mod-
est retardation in Src mobility. This can be explained by two 
  opposing effects of SH3 inactivation. First, it can increase Src 
kinase activity by decreasing the inhibitory intramolecular inter-
actions of the SH3 domain with SH2 kinase linker (Courtneidge, 
2002; Frame, 2004; Chong et al., 2005). On the other hand, 
it decreases intermolecular interactions with SH3 binding do-
mains in target proteins. These effects largely cancel out, but the 
modest additional mobility retardation after SH3 inactivation 
suggests that the increase in the activation of Src kinase has 
a higher contribution to the mobility-restricting interactions. 
This is in line with our conclusion that these interactions depend 
primarily on SH2-pTyr binding. These fi  ndings refl  ect what 
is known about the affi  nities of SH2 and SH3 domains. The 
affi  nity of SH2 domains to pTyr peptides is between 100 nM 
and 1 μM, whereas SH3 domains have weaker (micromolar) 
affi  nities for their target sites (Felder et al., 1993; Ladbury et al., 
1995; Mayer, 2001).
A model for processive phosphorylation by Src was pro-
posed based on studies with defi  ned Src target proteins (Mayer 
et al., 1995; Pellicena and Miller, 2001). In this model, the rela-
tively weak binding via the Src SH3 domain promotes initial 
phosphorylation of the substrate protein, leading to binding of 
SH2 to the resulting pTyr residue, stabilization of Src substrate 
interaction, and further substrate phosphorylation (Fig. 8 B). 
Here, we expand this model to explain the roles of Src domains 
in the dynamic regulation of its association with membrane sites 
(Fig. 8 A). We propose that Src-WT is dynamically associated 
with the inner membrane leafl  et through lipid-like interactions 
(Fig. 8 A). Activated Src retains the lipid anchor interactions, 
but in addition, binds transiently to TM and peripheral mem-
brane protein substrates, inhibiting its lateral diffusion and ex-
change. The Src SH2 domain promotes multisite processive 
phosphorylation (Fig. 8 B); this generates a positive feedback 
loop, with the SH2 domain successively promoting Src sub-
strate binding and further phosphorylation. Although weak SH3 
domain interactions may promote initial binding to substrates 
(Mayer et al., 1995; Pellicena and Miller, 2001), it is apparent 
that in cells expressing Src-Y527F, both the FRAP kinetics 
of active Src and the overall abundance of pTyr proteins are pri-
marily determined by the Src SH2 domain and its interactions 
with pTyr sites.
Activated Src binds not only to TM proteins but also to 
peripheral protein substrates, which may possess a considerable 
cytoplasmic population. According to the model (Fig. 8 A), 
overexpression of such a protein should compete with the bind-
ing of activated Src to target membrane proteins. Indeed, over-
expression of paxillin-DsRed2, which has a high cytosolic 
fraction similar to that of endogenous paxillin (Fig. 7 B), selec-
tively interfered with the mobility retardation of Src-GFP mu-
tants. Only Src mutants with both active kinase and intact SH2 
domain were highly affected by paxillin (Fig. 6), in line with the 
major role of Src kinase and SH2 domain in the interactions 
with membrane proteins. However, although Src-Y527F reverted 
to lipid-like membrane association, Src-Y527F/W118A (inacti-
vated SH3 domain) retained some mobility-retarding inter-
actions in the presence of overexpressed paxillin, suggesting 
less effective competition. Because paxillin contains both SH2 
and SH3 binding sites (Schaller, 2001; Cary et al., 2002), this 
suggests that, at least under overexpression conditions, SH3 
binding partially contributes to the competition by paxillin. It 
should be noted that competition by paxillin did not increase the 
Figure 8.  Interaction of Src with its substrates. 
(A) Lateral diffusion and membrane-cytosol ex-
change of free or substrate-bound Src. Inactive 
Src (1) interacts with the membrane primarily 
through its myristoyl anchor (purple) and the 
adjacent polybasic sequence and exhibits 
both lipid-like lateral diffusion and exchange 
with the cytosol. Upon activation, the open-
conformation, active Src binds transiently to 
TM substrates, retarding its lateral diffusion 
and exchange (2). The mobility-retarding inter-
actions depend mainly on SH2 domain inter-
actions with pTyr sites (high afﬁ   nity; blue 
arrows), with only a minor contribution of SH3 
domain binding (low afﬁ   nity; green arrows). 
Activated Src binds also to peripheral protein 
substrates, which compete for Src binding with 
the TM proteins (3 and 4). Upon binding to a 
peripheral protein that undergoes exchange 
between membrane and cytosolic pools, Src 
retains the N-terminal lipid-like membrane in-
teractions; the rates of exchange and lateral 
diffusion of Src in complex with the peripheral 
protein would be affected by the membrane 
interactions of the latter. (B) Dependence of 
Src substrate phosphorylation on the Src SH2 
domain: the processive multisite model. In this model, Src binds initially to the substrate (1) and phosphorylates it (red arrow; 2). This enhances the binding 
of Src to the substrate via its SH2 domain (3) and promotes further phosphorylation of the substrate at additional sites (processive phosphorylation; red 
arrows; 4). Other models that account for the SH2 dependence of Src substrate phosphorylation include protection of the pTyr residues (red circles) from 
pTyr protein phosphatases and targeting of Src to substrates by binding to other pTyr proteins.JCB • VOLUME 178 • NUMBER 4 • 2007  684
cytoplasmic fraction of Src-Y527F, in line with the retained 
lipid interactions of the Src lipid anchor, which effectively tar-
gets Src-WT to the membrane (Fig. 7 A). The membrane inter-
actions of Src–paxillin complexes may be somewhat enhanced, 
as indicated by the small increase in the membrane fraction of 
Src-Y527F after paxillin overexpression. This may refl  ect a 
contribution by the complexed paxillin to the targeting of Src to 
specifi  c structures/clusters, as shown by their partial colocaliza-
tion in the cells (Fig. 7 C).
The behavior of activated Src may have general implica-
tions for signaling by SFKs activated by physiological signals. 
Thus, the SFK Lyn was found both in the plasma membrane and 
the cytoplasm, and its lateral diffusion rate in the membrane 
was retarded after IgE receptor stimulation (Larson et al., 2005). 
The lateral diffusion of Lck, another SFK, was also retarded 
in response to cross-linking of T cell receptors (Kusumi et al., 
2005). In addition, recent fi  ndings support the idea that en-
hanced formation of Src complexes with targets such as integ-
rins and receptor tyrosine kinases is important for tumorigenesis 
(Guo et al., 2006). Thus, modulation of Src membrane inter-
actions by binding to membrane-associated target proteins is 
relevant to its biological functions, including cell migration and 
tumorigenesis. Further characterization of these complexes by 
both biophysical and biochemical approaches will therefore be 
of considerable interest.
Materials and methods
Reagents
Murine anti-vinculin (clone hVin-1) and anti-lactate dehydrogenase (clone 
HH-17) ascites were obtained from Sigma-Aldrich. Murine anti-paxillin and 
anti-FAK were obtained from BD Biosciences. Rabbit anti-GFP and anti-
caveolin1 were obtained from Santa Cruz Biotechnology, Inc. Murine anti-
pTyr mAb (clone 4G10) was obtained from Upstate Biotechnology. Cy3 
goat anti–mouse IgG and rabbit anti–mouse IgG were obtained from Jackson 
ImmunoResearch Laboratories. Goat anti–mouse IgG conjugated to IRDye 
800 was obtained from Rockland Immunochemicals, and Alexa 680 goat 
anti–rabbit IgG was obtained from Invitrogen. O-phospho-L-tyrosine was 
obtained from Sigma-Aldrich.
Plasmids
Expression vectors for Src-WT-GFP, Src-Y527F-GFP (both in pEGFP-N1), and 
Src-251-GFP (in pBabePuro) (Timpson et al., 2001; Sandilands et al., 2004) 
were donated by M. Frame (The Beatson Institute for Cancer Research, 
Glasgow, Scotland). Additional Src-GFP mutants (Table I) were generated 
by site-directed mutagenesis using QuikChange (Stratagene). The muta-
genic primers used are given in Table S1 (available at http://www.jcb
.org/cgi/content/full/jcb.200701133/DC1). Constitutively active human 
c-Src-Y530F (prepared from molecularly cloned human c-Src; Bjorge et al., 
1995) in pCI vector was a gift from D.J. Fujita (University of Calgary, 
Alberta, Canada). Chicken paxillin-DsRed2 in pDsRed2 (Webb et al., 2004) 
was donated by A.F. Horwitz (University of Virginia, Charlottesville, VA). 
This vector was used as a template to generate the paxillin-Y31F/Y118F-
DsRed2 double mutant by site-directed mutagenesis (QuikChange), using 
primers 5′-G  A  G  G  A  A  A  C  G  C  C  T  T  T  C  T  C  C  T  A  C  C  C  A  A  C  T  G  G  -3′ (forward) and 
5′-C  C  A  G  T  T  G  G  G  T  A  G  G  A  G  A  A  A  G  G  C  G  T  T  T  C  C  T  C  -3′ (reverse) for the Y31F 
mutation (underlined); the Y118F mutation was added to this mutant using 
primers 5′-G  T  G  A  G  G  A  G  G  A  A  C  A  C  G  T  G  T  T  C  A  G  C  T  T  C  C  C  -3′ (forward) and 
5′-G  G  G  A  A  G  C  T  G  A  A  C  A  C  G  T  G  T  T  C  C  T  C  C  T  C  A  C  -3′ (reverse).
Cell culture and transfections
COS-7 cells (American Type Culture Collection) were grown in DME con-
taining 10% FCS as described previously (Shvartsman et al., 2003). For 
FRAP and confocal microscopy, COS-7 cells grown on glass coverslips 
were transfected using DEAE-dextran (Seed and Aruffo, 1987) with plas-
mid DNA encoding one of the Src-GFP derivatives alone or together with 
a 10-fold excess of paxillin-DsRed2 or empty pDsRed2. For biochemical 
studies, the procedure was similar, except that cells were grown in 10-cm 
dishes and transfected using Lipofectamine 2000 (Invitrogen).
FRAP
COS-7 cells expressing Src-GFP proteins were taken for FRAP studies 24–
48 h after transfection. Measurements were in HBSS supplemented with 
20 mM Hepes, pH 7.2. In some experiments, cells were ﬁ  rst subjected to star-
vation in serum-free DME (16–20 h), followed by a 10-min incubation at 
37°C with or without 50 ng/ml PDGF (rhPDGF-BB; R & D Systems). To mini-
mize internalization, FRAP measurements were at 22°C, replacing samples 
within 15 min. An argon ion laser beam (Innova 70C; Coherent) was 
focused through a ﬂ  uorescence microscope (Universal; Carl Zeiss Micro-
Imaging, Inc.) to a Gaussian spot of 0.85 ± 0.02 μm (63× oil-immersion 
objective) or 1.36 ± 0.04 μm (40× objective), and experiments were con-
ducted with each beam size (beam-size analysis; Illenberger et al., 2003; 
Henis et al., 2006). The ratio between the illuminated areas was 2.56 ± 
0.30 (n = 39). After a brief measurement at monitoring intensity (488 nm, 
1 μW), a 5-mW pulse (5–10 ms) bleached 60–75% of the ﬂ  uorescence in 
the spot, and recovery was followed by the monitoring beam. The apparent 
characteristic ﬂ  uorescence recovery time τ and the mobile fraction (Rf) were 
extracted from the FRAP curves by nonlinear regression analysis, ﬁ  tting to 
a lateral diffusion process (Petersen et al., 1986).
Fluorescence confocal microscopy
Transfected cells were ﬁ  xed with 4% PFA in PBS. For antibody labeling, 
they were permeabilized with 0.2% Triton X-100 and immunostained as 
detailed in the speciﬁ  c ﬁ  gure legend. The cells were mounted with Prolong 
Antifade (Invitrogen). Fluorescence images were collected on a confocal 
microscope (LSM 510; Carl Zeiss MicroImaging, Inc.) with plan-apochromat 
100×/1.4 objective using LSM 510 (version 3.2 sp2) software and ex-
ported to Photoshop (Adobe).
Cell fractionation
COS-7 cells were grown and transfected with Src-GFP vectors (alone 
or together with paxillin-DsRed2) as described. After 24 h, the cells 
were suspended in hypotonic buffer (10 mM Hepes, pH 7.4, 10 mM KCl, 
3 mM MgCl2, 1 mM EDTA, 20 mM NaF, and 10 mM β-glycerophosphate) 
containing protease inhibitors (174 μg/ml PMSF, 1.5 μg/ml benzami-
dine, 1 μg/ml phenanthroline, 0.5 μg/ml antipain, 0.5 μg/ml leupeptin, 
0.5 μg/ml pepstatin, 0.5 μg/ml aprotinin, and 0.5 μg/ml chymostatin) 
and subjected to Dounce homogenization. After removal of nuclei and 
cell debris by low-speed centrifugation, particulate and soluble fractions 
were separated by centrifugation (106,000 g, 1 h, 4°C). Particulate frac-
tions were solubilized in a high-salt buffer (50 mM Hepes, pH 7.4, 250 mM 
KCl, 1.0% NP-40, 1 mM EDTA, 20 mM NaF, 10 mM β-glycerophosphate, 
and 5% glycerol) containing the protease inhibitors; 4× concentrated 
high-salt buffer was added to the soluble fractions (3:1, vol/vol). Equal 
proportions of the particulate and soluble fractions (5%, vol/vol) were 
analyzed by SDS-PAGE and immunoblotting. Blots were quantiﬁ   ed 
  using an imaging system (Odyssey IR; LI-COR) as detailed in the Immuno-
blotting section.
Construction and expression of GST fusion proteins with Src domains
To generate GST-Src domain DNA constructs, the DNA sequences encod-
ing each domain were ampliﬁ  ed by PCR and cloned into the pGEX-KG 
vector (Guan and Dixon, 1991). For plasmids encoding GST-SH3 (amino 
acids 79–147 of chicken c-Src), GST-SH2 (amino acids 148–251), and 
GST-SH3/SH2 (amino acids 79–251), Src-Y527F-GFP in pEGFP served as 
template. Plasmids encoding GST-SH3*/SH2 (containing a W118A SH3-
inactivating mutation) and GST-SH3/SH2* (containing an R175A SH2-
inactivating mutation) were generated similarly, except that Src double 
mutants in pEGFP (Src-Y527F/W118A-GFP and Src-Y527F/R175A-GFP, 
respectively) served as template. The primers used are detailed in Table S2 
(available at http://www.jcb.org/cgi/content/full/jcb.200701133/DC1). 
Forward and reverse primers contained a BamHI site and a HindIII site, 
respectively (Table S2). After digestion of the PCR product and the pGEX-KG 
vector with these enzymes, they were ligated to generate the pGEX-Src 
domain vectors. All constructs were conﬁ  rmed by sequencing. Bacteria 
transformed by the above plasmids were grown, sonicated, and lysed as 
described previously (Tian and Martin, 1997). The lysate from 8 ml bacte-
ria was rocked (1 h; 4°C) with 120 μl (packed volume) of glutathione–
Sepharose 4B beads (GE Healthcare). The beads were pelleted, washed 
ﬁ  ve times, and stored for short periods on ice in PBS containing 0.25% 
Tween 20 and the protease inhibitor cocktail described in the Cell fraction-
ation section.DYNAMICS OF SRC MEMBRANE INTERACTIONS • SHVARTSMAN ET AL. 685
GST fusion protein binding to pTyr-bearing proteins
At 48–72 h after transfection, COS-7 cells expressing speciﬁ  c Src-GFP pro-
teins were lysed in NP-40 lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 
5 mM EDTA, 1% NP-40, 50 mM NaF, and 200 μM Na3VO4) containing 
the protease inhibitors. Lysates were clariﬁ  ed by centrifugation, and ali-
quots (0.5 mg protein) were incubated for 1.5 h at 4°C with glutathione–
Sepharose beads bearing  30 μg of GST fusion protein (GST, GST-SH3, 
GST-SH2, GST-SH3/SH2, GST-SH3*/SH2, or GST-SH3/SH2*; described 
in Table S2). After four washes in lysis buffer, proteins bound to the beads 
were solubilized by boiling in SDS sample buffer, resolved by 8.5% SDS-
PAGE, and analyzed by immunoblotting using anti-pTyr antibodies.
Immunoprecipitation
COS-7 cells cotransfected by Src-WT-GFP or Src-Y527F-GFP and paxillin-
DsRed2 (or empty vector) were fractionated as described. 5% (vol/vol) of 
each fraction (soluble and particulate) in the high-salt buffer was taken to 
determine Src-GFP levels. The remaining 95% was immunoprecipitated by 
1.8 μg mouse anti-paxillin essentially as described previously (Donaldson 
et al., 2000). Immunoprecipitation of endogenous FAK was performed 
similarly on whole cell lysates using 2 μg mouse anti-FAK mAb. The beads 
were washed three times with the high-salt buffer. Bound material was solu-
bilized in SDS sample buffer, resolved by SDS-PAGE, and immunoblotted 
with anti-pTyr or anti-paxillin antibodies.
Immunoblotting
Blots were blocked in Odyssey blocking buffer (OBB; LI-COR) diluted 1:1 
with PBS and incubated (12 h; 4°C) with primary antibodies (1 μg/ml anti-
pTyr, 0.4 μg/ml anti-GFP, 0.25 μg/ml anti-paxillin, 0.25 μg/ml anti-FAK, 
and 1:500 dilution of anti-lactate dehydrogenase ascites or 0.2 μg/ml 
anti-caveolin1) in OBB containing 0.2% Tween 20. They were then incu-
bated (1 h, 22°C) with secondary antibodies (0.1 μg/ml goat anti–mouse 
or 0.2 μg/ml goat anti–rabbit IgG coupled to IR dyes) in OBB containing 
0.2% Tween 20 and 0.01% SDS. The blots were quantiﬁ  ed using the 
Odyssey IR imaging system (LI-COR).
Online supplemental material
Table S1 lists the primers used to generate double and triple chicken c-Src 
mutants. Table S2 depicts the pGEX-KG plasmids encoding GST-Src do-
main fusion proteins and the primers used to generate them. Fig. S1 shows 
that GST-Src domain fusion proteins speciﬁ  cally precipitate pTyr proteins 
from lysates of cells expressing Src-GFP mutants. Fig. S2 shows that over-
expression of paxillin-DsRed2 reduces the coimmunoprecipitation of Src-
Y527F with FAK. Online supplemental material is available at http://www
.jcb.org/cgi/content/full/jcb.200701133/DC1.
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